Myovant Sciences
$7.659876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$7.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.05 (-0.65%) Today
$0.00 (0.00%) As of 4:02 PM EDT after-hours
Why Robinhood?
You can buy or sell MYOV and other stocks, options, ETFs, and crypto commission-free!
About MYOV
Myovant Sciences Ltd., also called Myovant Sciences, is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of women's health and endocrine diseases. Read More The company's product includes relugolix, which is an oral, once-daily and small molecule that acts as a GnRH receptor antagonist. It also develops MVT-602 a kisspeptin agonist for the treatment of female infertility. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom.
CEO
Employees
167
Headquarters
London, Greater London
Founded
2016
Market Cap
552.31M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
190.67K
High Today
$7.74
Low Today
$7.50
Open Price
$7.65
Volume
125.44K
52 Week High
$27.45
52 Week Low
$6.60
Collections
Price Paid on Robinhood
58% Lower
Right Now
52 Week Low
$14.32
Average Price Paid
$18.03
52 Week High
$27.45
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
MYOV Earnings
-$1.07
-$0.88
-$0.70
-$0.51
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
—
Actual
Expected Nov 7, After Hours